Inovio Pharmaceuticals Inc (INO)
10.36
+0.36
(+3.60%)
USD |
NASDAQ |
Apr 23, 16:00
10.36
0.00 (0.00%)
After-Hours: 20:00
Inovio Pharmaceuticals Total Liabilities (Quarterly): 53.60M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 53.60M |
| September 30, 2023 | 54.94M |
| June 30, 2023 | 63.67M |
| March 31, 2023 | 67.37M |
| December 31, 2022 | 126.17M |
| September 30, 2022 | 125.27M |
| June 30, 2022 | 161.73M |
| March 31, 2022 | 90.43M |
| December 31, 2021 | 96.27M |
| September 30, 2021 | 82.19M |
| June 30, 2021 | 83.29M |
| March 31, 2021 | 73.26M |
| December 31, 2020 | 78.63M |
| September 30, 2020 | 113.81M |
| June 30, 2020 | 256.82M |
| March 31, 2020 | 151.07M |
| December 31, 2019 | 138.55M |
| September 30, 2019 | 115.41M |
| June 30, 2019 | 108.60M |
| March 31, 2019 | 110.20M |
| December 31, 2018 | 44.08M |
| September 30, 2018 | 36.99M |
| June 30, 2018 | 37.43M |
| March 31, 2018 | 60.57M |
| December 31, 2017 | 44.75M |
| Date | Value |
|---|---|
| September 30, 2017 | 41.56M |
| June 30, 2017 | 35.32M |
| March 31, 2017 | 47.37M |
| December 31, 2016 | 50.33M |
| September 30, 2016 | 47.57M |
| June 30, 2016 | 41.90M |
| March 31, 2016 | 40.07M |
| December 31, 2015 | 37.91M |
| September 30, 2015 | 37.39M |
| June 30, 2015 | 20.75M |
| March 31, 2015 | 14.43M |
| December 31, 2014 | 20.25M |
| September 30, 2014 | 17.49M |
| June 30, 2014 | 19.88M |
| March 31, 2014 | 22.48M |
| December 31, 2013 | 35.38M |
| September 30, 2013 | 25.80M |
| June 30, 2013 | 21.32M |
| March 31, 2013 | 17.78M |
| December 31, 2012 | 10.28M |
| September 30, 2012 | 13.20M |
| June 30, 2012 | 12.24M |
| March 31, 2012 | 15.12M |
| December 31, 2011 | 13.24M |
| September 30, 2011 | 11.96M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
53.60M
Minimum
Dec 2023
256.82M
Maximum
Jun 2020
107.42M
Average
96.27M
Median
Dec 2021
Total Liabilities (Quarterly) Benchmarks
| Cerus Corp | 144.30M |
| Stereotaxis Inc | 19.99M |
| Viemed Healthcare Inc | 41.00M |
| AIM ImmunoTech Inc | 9.147M |
| Protalix BioTherapeutics Inc | 50.86M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 170.95M |
| Shareholders Equity (Quarterly) | 117.35M |
| Debt to Equity Ratio | 0.1429 |
| Current Ratio | 3.597 |
| Net Debt Paydown Yield | -0.07% |